Research indicates that Ipamorelin can trigger the release of insulin from the pancreas, as well as enhance gastric functioning and bowel mobility [1]
Although glucagon is traditionally understood as a counter-regulatory hormone that increases hepatic glucose production, its pharmacologic activation in balanced multi-receptor agonists may contribute to weight reduction by increasing energy expenditure, promoting fatty acid oxidation, and improving hepatic lipid metabolism
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
WADA Prohibited List (2025), Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics (Insulin-like Growth Factor-1 and its analogues)
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
When obesity-related differences are not adequately studied or communicated, prescribing decisions may be made without the information needed to optimize treatment
